nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CMA1—asthma	0.433	1	CbGaD
Boceprevir—CYP3A5—Salmeterol—asthma	0.0214	0.0764	CbGbCtD
Boceprevir—CYP3A5—Beclomethasone—asthma	0.0214	0.0764	CbGbCtD
Boceprevir—ABCB1—Fluticasone furoate—asthma	0.0184	0.0656	CbGbCtD
Boceprevir—CYP3A5—Fluticasone Propionate—asthma	0.0182	0.0649	CbGbCtD
Boceprevir—ABCB1—Indacaterol—asthma	0.015	0.0535	CbGbCtD
Boceprevir—CYP3A4—Fluticasone furoate—asthma	0.011	0.0393	CbGbCtD
Boceprevir—CYP3A4—Budesonide—asthma	0.00983	0.035	CbGbCtD
Boceprevir—CYP3A4—Indacaterol—asthma	0.00899	0.032	CbGbCtD
Boceprevir—CYP3A4—Ciclesonide—asthma	0.00899	0.032	CbGbCtD
Boceprevir—CYP3A4—Flunisolide—asthma	0.00836	0.0298	CbGbCtD
Boceprevir—CYP3A4—Salbutamol—asthma	0.00836	0.0298	CbGbCtD
Boceprevir—CYP3A4—Salmeterol—asthma	0.00836	0.0298	CbGbCtD
Boceprevir—ABCB1—Loratadine—asthma	0.00801	0.0285	CbGbCtD
Boceprevir—CYP3A4—Zileuton—asthma	0.00745	0.0265	CbGbCtD
Boceprevir—CYP3A4—Ipratropium bromide—asthma	0.00745	0.0265	CbGbCtD
Boceprevir—ABCB1—Methylprednisolone—asthma	0.00733	0.0261	CbGbCtD
Boceprevir—CYP3A4—Fluticasone Propionate—asthma	0.0071	0.0253	CbGbCtD
Boceprevir—CYP3A5—Hydrocortisone—asthma	0.00685	0.0244	CbGbCtD
Boceprevir—CYP3A4—Zafirlukast—asthma	0.00656	0.0234	CbGbCtD
Boceprevir—CYP3A4—Tiotropium—asthma	0.00564	0.0201	CbGbCtD
Boceprevir—CYP3A4—Aminophylline—asthma	0.00538	0.0192	CbGbCtD
Boceprevir—CYP3A4—Theophylline—asthma	0.00506	0.018	CbGbCtD
Boceprevir—CYP3A4—Loratadine—asthma	0.0048	0.0171	CbGbCtD
Boceprevir—CYP3A4—Montelukast—asthma	0.0048	0.0171	CbGbCtD
Boceprevir—ABCB1—Betamethasone—asthma	0.00476	0.017	CbGbCtD
Boceprevir—ABCB1—Prednisolone—asthma	0.0047	0.0168	CbGbCtD
Boceprevir—ABCB1—Hydrocortisone—asthma	0.00446	0.0159	CbGbCtD
Boceprevir—ABCB1—Prednisone—asthma	0.00444	0.0158	CbGbCtD
Boceprevir—CYP3A4—Methylprednisolone—asthma	0.00439	0.0156	CbGbCtD
Boceprevir—CYP3A5—Dexamethasone—asthma	0.00426	0.0152	CbGbCtD
Boceprevir—Telaprevir—CMA1—asthma	0.00379	0.92	CrCbGaD
Boceprevir—CTSL—exocrine gland—asthma	0.00363	0.0722	CbGeAlD
Boceprevir—CYP3A4—Triamcinolone—asthma	0.00333	0.0119	CbGbCtD
Boceprevir—CYP3A4—Betamethasone—asthma	0.00285	0.0102	CbGbCtD
Boceprevir—CYP3A4—Prednisolone—asthma	0.00282	0.01	CbGbCtD
Boceprevir—ABCB1—Dexamethasone—asthma	0.00277	0.00988	CbGbCtD
Boceprevir—CYP3A4—Hydrocortisone—asthma	0.00267	0.00951	CbGbCtD
Boceprevir—CYP3A4—Prednisone—asthma	0.00266	0.00948	CbGbCtD
Boceprevir—CTSS—exocrine gland—asthma	0.0024	0.0476	CbGeAlD
Boceprevir—CMA1—respiratory system—asthma	0.00221	0.0439	CbGeAlD
Boceprevir—CTSV—bronchus—asthma	0.0019	0.0378	CbGeAlD
Boceprevir—CTSL—respiratory system—asthma	0.00189	0.0376	CbGeAlD
Boceprevir—CMA1—smooth muscle tissue—asthma	0.00178	0.0354	CbGeAlD
Boceprevir—CTSV—trachea—asthma	0.00171	0.034	CbGeAlD
Boceprevir—CMA1—cardiovascular system—asthma	0.00169	0.0336	CbGeAlD
Boceprevir—CYP3A4—Dexamethasone—asthma	0.00166	0.00592	CbGbCtD
Boceprevir—CTSL—adrenal cortex—asthma	0.00159	0.0315	CbGeAlD
Boceprevir—CTSL—epithelium—asthma	0.00158	0.0314	CbGeAlD
Boceprevir—CTSL—bronchus—asthma	0.00156	0.0309	CbGeAlD
Boceprevir—CTSL—smooth muscle tissue—asthma	0.00152	0.0302	CbGeAlD
Boceprevir—CTSL—cardiovascular system—asthma	0.00145	0.0288	CbGeAlD
Boceprevir—CTSK—respiratory system—asthma	0.00142	0.0283	CbGeAlD
Boceprevir—CTSL—trachea—asthma	0.0014	0.0278	CbGeAlD
Boceprevir—CMA1—adrenal gland—asthma	0.00134	0.0266	CbGeAlD
Boceprevir—CTSS—respiratory system—asthma	0.00125	0.0248	CbGeAlD
Boceprevir—CTSV—lung—asthma	0.00123	0.0244	CbGeAlD
Boceprevir—CTSK—adrenal cortex—asthma	0.00119	0.0238	CbGeAlD
Boceprevir—CMA1—lung—asthma	0.00117	0.0233	CbGeAlD
Boceprevir—CTSK—bronchus—asthma	0.00117	0.0233	CbGeAlD
Boceprevir—CTSK—smooth muscle tissue—asthma	0.00115	0.0228	CbGeAlD
Boceprevir—CTSL—adrenal gland—asthma	0.00114	0.0228	CbGeAlD
Boceprevir—CTSK—cardiovascular system—asthma	0.00109	0.0217	CbGeAlD
Boceprevir—CTSK—trachea—asthma	0.00105	0.0209	CbGeAlD
Boceprevir—CTSS—adrenal cortex—asthma	0.00105	0.0208	CbGeAlD
Boceprevir—CTSS—bronchus—asthma	0.00103	0.0204	CbGeAlD
Boceprevir—CTSS—smooth muscle tissue—asthma	0.001	0.02	CbGeAlD
Boceprevir—CTSL—lung—asthma	0.001	0.0199	CbGeAlD
Boceprevir—CTSS—cardiovascular system—asthma	0.000956	0.019	CbGeAlD
Boceprevir—CTSS—trachea—asthma	0.000922	0.0183	CbGeAlD
Boceprevir—CTSK—adrenal gland—asthma	0.000863	0.0171	CbGeAlD
Boceprevir—CTSK—lung—asthma	0.000756	0.015	CbGeAlD
Boceprevir—CTSS—adrenal gland—asthma	0.000756	0.015	CbGeAlD
Boceprevir—CTSS—lung—asthma	0.000662	0.0132	CbGeAlD
Boceprevir—CTSL—Carbidopa—Isoprenaline—asthma	0.000457	0.166	CbGdCrCtD
Boceprevir—CYP3A5—respiratory system—asthma	0.000414	0.00824	CbGeAlD
Boceprevir—Telaprevir—ALB—asthma	0.000328	0.0796	CrCbGaD
Boceprevir—ABCB1—respiratory system—asthma	0.00022	0.00437	CbGeAlD
Boceprevir—CYP3A5—lung—asthma	0.00022	0.00437	CbGeAlD
Boceprevir—CTSL—Fluticasone Propionate—Fluticasone furoate—asthma	0.000219	0.0795	CbGdCrCtD
Boceprevir—ABCB1—adrenal cortex—asthma	0.000185	0.00367	CbGeAlD
Boceprevir—ABCB1—epithelium—asthma	0.000184	0.00366	CbGeAlD
Boceprevir—ABCB1—cardiovascular system—asthma	0.000169	0.00335	CbGeAlD
Boceprevir—ABCB1—trachea—asthma	0.000163	0.00323	CbGeAlD
Boceprevir—CTSL—Fluticasone Propionate—Beclomethasone—asthma	0.00015	0.0545	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Flunisolide—asthma	0.000142	0.0515	CbGdCrCtD
Boceprevir—ABCB1—adrenal gland—asthma	0.000133	0.00265	CbGeAlD
Boceprevir—ABCB1—lung—asthma	0.000117	0.00232	CbGeAlD
Boceprevir—CTSL—Fluticasone Propionate—Mometasone—asthma	0.000117	0.0422	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Fluticasone furoate—asthma	0.000111	0.0403	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Fluticasone furoate—asthma	0.000111	0.0403	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Fluticasone Propionate—asthma	0.000104	0.0376	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Fluticasone Propionate—asthma	0.000104	0.0376	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Beclomethasone—asthma	7.62e-05	0.0276	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Beclomethasone—asthma	7.62e-05	0.0276	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Budesonide—asthma	7.31e-05	0.0265	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Budesonide—asthma	7.31e-05	0.0265	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Flunisolide—asthma	7.21e-05	0.0261	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Flunisolide—asthma	7.21e-05	0.0261	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Methylprednisolone—asthma	6.96e-05	0.0252	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Dexamethasone—asthma	6.85e-05	0.0248	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Betamethasone—asthma	6.85e-05	0.0248	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Triamcinolone—asthma	6.69e-05	0.0243	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Mometasone—asthma	5.91e-05	0.0214	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Mometasone—asthma	5.91e-05	0.0214	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Hydrocortisone—asthma	3.74e-05	0.0136	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Hydrocortisone—asthma	3.74e-05	0.0136	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Methylprednisolone—asthma	3.53e-05	0.0128	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Methylprednisolone—asthma	3.53e-05	0.0128	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Dexamethasone—asthma	3.47e-05	0.0126	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Betamethasone—asthma	3.47e-05	0.0126	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Triamcinolone—asthma	3.39e-05	0.0123	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Triamcinolone—asthma	3.39e-05	0.0123	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Prednisone—asthma	3.22e-05	0.0117	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Prednisone—asthma	3.22e-05	0.0117	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Prednisolone—asthma	3.14e-05	0.0114	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Prednisolone—asthma	3.14e-05	0.0114	CbGdCrCtD
Boceprevir—CTSK—Adaptive Immune System—CD4—asthma	2.23e-05	0.000259	CbGpPWpGaD
Boceprevir—CTSS—Immune System—VCAM1—asthma	2.23e-05	0.000259	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ICAM1—asthma	2.22e-05	0.000258	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ICAM1—asthma	2.22e-05	0.000258	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HLA-DQA1—asthma	2.22e-05	0.000258	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ADCY2—asthma	2.21e-05	0.000256	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL3—asthma	2.2e-05	0.000255	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PPP2CA—asthma	2.19e-05	0.000255	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—HLA-DRB1—asthma	2.19e-05	0.000255	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—CXCL8—asthma	2.19e-05	0.000255	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL2RA—asthma	2.12e-05	0.000247	CbGpPWpGaD
Boceprevir—Erythema—Betamethasone—asthma	2.11e-05	0.000147	CcSEcCtD
Boceprevir—CYP3A5—Biological oxidations—GSTP1—asthma	2.11e-05	0.000245	CbGpPWpGaD
Boceprevir—CTSK—Immune System—C3—asthma	2.1e-05	0.000245	CbGpPWpGaD
Boceprevir—Myalgia—Hydrocortisone—asthma	2.1e-05	0.000146	CcSEcCtD
Boceprevir—CTSS—Immune System—ITPR1—asthma	2.1e-05	0.000244	CbGpPWpGaD
Boceprevir—Malaise—Triamcinolone—asthma	2.09e-05	0.000146	CcSEcCtD
Boceprevir—Anxiety—Hydrocortisone—asthma	2.09e-05	0.000146	CcSEcCtD
Boceprevir—Malaise—Methylprednisolone—asthma	2.09e-05	0.000146	CcSEcCtD
Boceprevir—Vertigo—Triamcinolone—asthma	2.09e-05	0.000146	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	2.09e-05	0.000145	CcSEcCtD
Boceprevir—Syncope—Triamcinolone—asthma	2.08e-05	0.000145	CcSEcCtD
Boceprevir—Vertigo—Methylprednisolone—asthma	2.08e-05	0.000145	CcSEcCtD
Boceprevir—Syncope—Methylprednisolone—asthma	2.08e-05	0.000145	CcSEcCtD
Boceprevir—CYP3A5—Metapathway biotransformation—GSTP1—asthma	2.08e-05	0.000242	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HLA-DQB1—asthma	2.08e-05	0.000241	CbGpPWpGaD
Boceprevir—Discomfort—Hydrocortisone—asthma	2.08e-05	0.000145	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—KNG1—asthma	2.07e-05	0.000241	CbGpPWpGaD
Boceprevir—Connective tissue disorder—Prednisone—asthma	2.07e-05	0.000144	CcSEcCtD
Boceprevir—Nausea—Budesonide—asthma	2.07e-05	0.000144	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—AGTR1—asthma	2.06e-05	0.00024	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PDGFB—asthma	2.05e-05	0.000238	CbGpPWpGaD
Boceprevir—Loss of consciousness—Triamcinolone—asthma	2.04e-05	0.000142	CcSEcCtD
Boceprevir—Loss of consciousness—Methylprednisolone—asthma	2.04e-05	0.000142	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—asthma	2.03e-05	0.000236	CbGpPWpGaD
Boceprevir—Shock—Prednisolone—asthma	2.03e-05	0.000141	CcSEcCtD
Boceprevir—Cough—Triamcinolone—asthma	2.03e-05	0.000141	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CXCL10—asthma	2.01e-05	0.000234	CbGpPWpGaD
Boceprevir—Tachycardia—Prednisolone—asthma	2.01e-05	0.00014	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—PTEN—asthma	2.01e-05	0.000234	CbGpPWpGaD
Boceprevir—Hypertension—Triamcinolone—asthma	2.01e-05	0.00014	CcSEcCtD
Boceprevir—CTSK—Immune System—CRP—asthma	2e-05	0.000233	CbGpPWpGaD
Boceprevir—Hypertension—Methylprednisolone—asthma	2e-05	0.00014	CcSEcCtD
Boceprevir—Infection—Hydrocortisone—asthma	2e-05	0.000139	CcSEcCtD
Boceprevir—CTSS—Immune System—CD86—asthma	2e-05	0.000232	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—BCL2—asthma	2e-05	0.000232	CbGpPWpGaD
Boceprevir—Hyperhidrosis—Prednisolone—asthma	1.99e-05	0.000139	CcSEcCtD
Boceprevir—CTSV—Immune System—IL6R—asthma	1.98e-05	0.00023	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6R—asthma	1.98e-05	0.00023	CbGpPWpGaD
Boceprevir—Shock—Hydrocortisone—asthma	1.98e-05	0.000138	CcSEcCtD
Boceprevir—Myalgia—Triamcinolone—asthma	1.98e-05	0.000138	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—NTRK1—asthma	1.98e-05	0.00023	CbGpPWpGaD
Boceprevir—Nervous system disorder—Hydrocortisone—asthma	1.97e-05	0.000138	CcSEcCtD
Boceprevir—Arthralgia—Methylprednisolone—asthma	1.97e-05	0.000138	CcSEcCtD
Boceprevir—Myalgia—Methylprednisolone—asthma	1.97e-05	0.000138	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—EGFR—asthma	1.97e-05	0.000229	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—EGFR—asthma	1.97e-05	0.000229	CbGpPWpGaD
Boceprevir—Eye disorder—Prednisone—asthma	1.97e-05	0.000137	CcSEcCtD
Boceprevir—CTSS—Immune System—IL18—asthma	1.97e-05	0.000229	CbGpPWpGaD
Boceprevir—Anxiety—Methylprednisolone—asthma	1.97e-05	0.000137	CcSEcCtD
Boceprevir—Tachycardia—Hydrocortisone—asthma	1.97e-05	0.000137	CcSEcCtD
Boceprevir—CTSS—Immune System—CD40LG—asthma	1.96e-05	0.000228	CbGpPWpGaD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	1.96e-05	0.000137	CcSEcCtD
Boceprevir—Flushing—Prednisone—asthma	1.96e-05	0.000136	CcSEcCtD
Boceprevir—Skin disorder—Hydrocortisone—asthma	1.96e-05	0.000136	CcSEcCtD
Boceprevir—Ill-defined disorder—Dexamethasone—asthma	1.96e-05	0.000136	CcSEcCtD
Boceprevir—Ill-defined disorder—Betamethasone—asthma	1.96e-05	0.000136	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—ADRB2—asthma	1.96e-05	0.000227	CbGpPWpGaD
Boceprevir—Discomfort—Triamcinolone—asthma	1.95e-05	0.000136	CcSEcCtD
Boceprevir—Discomfort—Methylprednisolone—asthma	1.95e-05	0.000136	CcSEcCtD
Boceprevir—Hyperhidrosis—Hydrocortisone—asthma	1.95e-05	0.000136	CcSEcCtD
Boceprevir—CTSS—Immune System—CSF2—asthma	1.94e-05	0.000225	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD8A—asthma	1.94e-05	0.000225	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—GSTM1—asthma	1.94e-05	0.000225	CbGpPWpGaD
Boceprevir—Dry mouth—Triamcinolone—asthma	1.93e-05	0.000135	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—PTEN—asthma	1.93e-05	0.000224	CbGpPWpGaD
Boceprevir—Angioedema—Dexamethasone—asthma	1.93e-05	0.000134	CcSEcCtD
Boceprevir—Angioedema—Betamethasone—asthma	1.93e-05	0.000134	CcSEcCtD
Boceprevir—CTSK—Immune System—TLR4—asthma	1.92e-05	0.000223	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HLA-DRB1—asthma	1.92e-05	0.000223	CbGpPWpGaD
Boceprevir—Angiopathy—Prednisone—asthma	1.91e-05	0.000133	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CD4—asthma	1.91e-05	0.000222	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—GSTM1—asthma	1.91e-05	0.000222	CbGpPWpGaD
Boceprevir—Confusional state—Methylprednisolone—asthma	1.91e-05	0.000133	CcSEcCtD
Boceprevir—Immune system disorder—Prednisone—asthma	1.9e-05	0.000133	CcSEcCtD
Boceprevir—Malaise—Dexamethasone—asthma	1.9e-05	0.000133	CcSEcCtD
Boceprevir—Malaise—Betamethasone—asthma	1.9e-05	0.000133	CcSEcCtD
Boceprevir—Vertigo—Dexamethasone—asthma	1.89e-05	0.000132	CcSEcCtD
Boceprevir—Vertigo—Betamethasone—asthma	1.89e-05	0.000132	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—EGFR—asthma	1.89e-05	0.00022	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—EGFR—asthma	1.89e-05	0.00022	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AGER—asthma	1.89e-05	0.00022	CbGpPWpGaD
Boceprevir—Syncope—Dexamethasone—asthma	1.89e-05	0.000132	CcSEcCtD
Boceprevir—Syncope—Betamethasone—asthma	1.89e-05	0.000132	CcSEcCtD
Boceprevir—Arrhythmia—Prednisone—asthma	1.88e-05	0.000131	CcSEcCtD
Boceprevir—Infection—Triamcinolone—asthma	1.88e-05	0.000131	CcSEcCtD
Boceprevir—Hypotension—Hydrocortisone—asthma	1.88e-05	0.000131	CcSEcCtD
Boceprevir—Infection—Methylprednisolone—asthma	1.88e-05	0.000131	CcSEcCtD
Boceprevir—Shock—Triamcinolone—asthma	1.87e-05	0.00013	CcSEcCtD
Boceprevir—Insomnia—Prednisolone—asthma	1.86e-05	0.00013	CcSEcCtD
Boceprevir—Alopecia—Prednisone—asthma	1.86e-05	0.00013	CcSEcCtD
Boceprevir—Shock—Methylprednisolone—asthma	1.86e-05	0.00013	CcSEcCtD
Boceprevir—Nervous system disorder—Methylprednisolone—asthma	1.86e-05	0.000129	CcSEcCtD
Boceprevir—Loss of consciousness—Dexamethasone—asthma	1.85e-05	0.000129	CcSEcCtD
Boceprevir—Loss of consciousness—Betamethasone—asthma	1.85e-05	0.000129	CcSEcCtD
Boceprevir—Paraesthesia—Prednisolone—asthma	1.85e-05	0.000129	CcSEcCtD
Boceprevir—Tachycardia—Triamcinolone—asthma	1.85e-05	0.000129	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—ITPR1—asthma	1.85e-05	0.000215	CbGpPWpGaD
Boceprevir—Mental disorder—Prednisone—asthma	1.85e-05	0.000129	CcSEcCtD
Boceprevir—Tachycardia—Methylprednisolone—asthma	1.85e-05	0.000129	CcSEcCtD
Boceprevir—CTSK—Immune System—ICAM1—asthma	1.84e-05	0.000214	CbGpPWpGaD
Boceprevir—Skin disorder—Methylprednisolone—asthma	1.84e-05	0.000128	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CD4—asthma	1.84e-05	0.000213	CbGpPWpGaD
Boceprevir—Erythema—Prednisone—asthma	1.84e-05	0.000128	CcSEcCtD
Boceprevir—Malnutrition—Prednisone—asthma	1.84e-05	0.000128	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Hydrocortisone—asthma	1.83e-05	0.000128	CcSEcCtD
Boceprevir—Hyperhidrosis—Triamcinolone—asthma	1.83e-05	0.000128	CcSEcCtD
Boceprevir—Hyperhidrosis—Methylprednisolone—asthma	1.83e-05	0.000127	CcSEcCtD
Boceprevir—Insomnia—Hydrocortisone—asthma	1.82e-05	0.000127	CcSEcCtD
Boceprevir—Hypertension—Dexamethasone—asthma	1.82e-05	0.000127	CcSEcCtD
Boceprevir—Hypertension—Betamethasone—asthma	1.82e-05	0.000127	CcSEcCtD
Boceprevir—Paraesthesia—Hydrocortisone—asthma	1.81e-05	0.000126	CcSEcCtD
Boceprevir—CTSS—Immune System—PPP2CA—asthma	1.81e-05	0.00021	CbGpPWpGaD
Boceprevir—Myalgia—Dexamethasone—asthma	1.79e-05	0.000125	CcSEcCtD
Boceprevir—Myalgia—Betamethasone—asthma	1.79e-05	0.000125	CcSEcCtD
Boceprevir—Anxiety—Dexamethasone—asthma	1.79e-05	0.000125	CcSEcCtD
Boceprevir—Anxiety—Betamethasone—asthma	1.79e-05	0.000125	CcSEcCtD
Boceprevir—Discomfort—Dexamethasone—asthma	1.77e-05	0.000124	CcSEcCtD
Boceprevir—Discomfort—Betamethasone—asthma	1.77e-05	0.000124	CcSEcCtD
Boceprevir—Dyspepsia—Hydrocortisone—asthma	1.77e-05	0.000124	CcSEcCtD
Boceprevir—Hypotension—Methylprednisolone—asthma	1.77e-05	0.000123	CcSEcCtD
Boceprevir—Pain—Prednisolone—asthma	1.76e-05	0.000123	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CD86—asthma	1.76e-05	0.000205	CbGpPWpGaD
Boceprevir—Decreased appetite—Hydrocortisone—asthma	1.75e-05	0.000122	CcSEcCtD
Boceprevir—CTSS—Immune System—IL2RA—asthma	1.75e-05	0.000203	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EDN1—asthma	1.75e-05	0.000203	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—asthma	1.74e-05	0.000202	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Hydrocortisone—asthma	1.74e-05	0.000121	CcSEcCtD
Boceprevir—Fatigue—Hydrocortisone—asthma	1.74e-05	0.000121	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CCL5—asthma	1.73e-05	0.000202	CbGpPWpGaD
Boceprevir—CTSS—Immune System—C3—asthma	1.73e-05	0.000201	CbGpPWpGaD
Boceprevir—Vision blurred—Prednisone—asthma	1.73e-05	0.000121	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PLA2G4A—asthma	1.73e-05	0.000201	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Triamcinolone—asthma	1.73e-05	0.00012	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Methylprednisolone—asthma	1.72e-05	0.00012	CcSEcCtD
Boceprevir—Pain—Hydrocortisone—asthma	1.72e-05	0.00012	CcSEcCtD
Boceprevir—Insomnia—Triamcinolone—asthma	1.71e-05	0.00012	CcSEcCtD
Boceprevir—Insomnia—Methylprednisolone—asthma	1.71e-05	0.000119	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—asthma	1.71e-05	0.000199	CbGpPWpGaD
Boceprevir—Infection—Dexamethasone—asthma	1.71e-05	0.000119	CcSEcCtD
Boceprevir—Infection—Betamethasone—asthma	1.71e-05	0.000119	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CSF2—asthma	1.71e-05	0.000199	CbGpPWpGaD
Boceprevir—CTSV—Immune System—BCL2—asthma	1.71e-05	0.000198	CbGpPWpGaD
Boceprevir—CTSL—Immune System—BCL2—asthma	1.71e-05	0.000198	CbGpPWpGaD
Boceprevir—Ill-defined disorder—Prednisone—asthma	1.7e-05	0.000119	CcSEcCtD
Boceprevir—Paraesthesia—Triamcinolone—asthma	1.7e-05	0.000119	CcSEcCtD
Boceprevir—Feeling abnormal—Prednisolone—asthma	1.7e-05	0.000118	CcSEcCtD
Boceprevir—Paraesthesia—Methylprednisolone—asthma	1.7e-05	0.000118	CcSEcCtD
Boceprevir—Anaemia—Prednisone—asthma	1.7e-05	0.000118	CcSEcCtD
Boceprevir—Shock—Betamethasone—asthma	1.69e-05	0.000118	CcSEcCtD
Boceprevir—Shock—Dexamethasone—asthma	1.69e-05	0.000118	CcSEcCtD
Boceprevir—Dyspnoea—Triamcinolone—asthma	1.69e-05	0.000118	CcSEcCtD
Boceprevir—CTSV—Immune System—IFNG—asthma	1.69e-05	0.000196	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IFNG—asthma	1.69e-05	0.000196	CbGpPWpGaD
Boceprevir—Nervous system disorder—Dexamethasone—asthma	1.69e-05	0.000118	CcSEcCtD
Boceprevir—Nervous system disorder—Betamethasone—asthma	1.69e-05	0.000118	CcSEcCtD
Boceprevir—Agitation—Prednisone—asthma	1.69e-05	0.000118	CcSEcCtD
Boceprevir—CTSS—Immune System—PDGFB—asthma	1.69e-05	0.000196	CbGpPWpGaD
Boceprevir—Thrombocytopenia—Betamethasone—asthma	1.68e-05	0.000117	CcSEcCtD
Boceprevir—Thrombocytopenia—Dexamethasone—asthma	1.68e-05	0.000117	CcSEcCtD
Boceprevir—Tachycardia—Betamethasone—asthma	1.68e-05	0.000117	CcSEcCtD
Boceprevir—Tachycardia—Dexamethasone—asthma	1.68e-05	0.000117	CcSEcCtD
Boceprevir—Angioedema—Prednisone—asthma	1.68e-05	0.000117	CcSEcCtD
Boceprevir—Dyspepsia—Triamcinolone—asthma	1.67e-05	0.000116	CcSEcCtD
Boceprevir—Dyspepsia—Methylprednisolone—asthma	1.67e-05	0.000116	CcSEcCtD
Boceprevir—Hyperhidrosis—Dexamethasone—asthma	1.66e-05	0.000116	CcSEcCtD
Boceprevir—Hyperhidrosis—Betamethasone—asthma	1.66e-05	0.000116	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—SMAD3—asthma	1.66e-05	0.000193	CbGpPWpGaD
Boceprevir—Feeling abnormal—Hydrocortisone—asthma	1.66e-05	0.000116	CcSEcCtD
Boceprevir—Malaise—Prednisone—asthma	1.66e-05	0.000115	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—PTEN—asthma	1.66e-05	0.000192	CbGpPWpGaD
Boceprevir—Vertigo—Prednisone—asthma	1.65e-05	0.000115	CcSEcCtD
Boceprevir—CTSS—Immune System—CRP—asthma	1.65e-05	0.000192	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Hydrocortisone—asthma	1.65e-05	0.000115	CcSEcCtD
Boceprevir—Syncope—Prednisone—asthma	1.65e-05	0.000115	CcSEcCtD
Boceprevir—CTSK—Immune System—IL6R—asthma	1.64e-05	0.000191	CbGpPWpGaD
Boceprevir—Urticaria—Prednisolone—asthma	1.64e-05	0.000114	CcSEcCtD
Boceprevir—Fatigue—Triamcinolone—asthma	1.63e-05	0.000114	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—EGFR—asthma	1.63e-05	0.00019	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD4—asthma	1.63e-05	0.00019	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD4—asthma	1.63e-05	0.00019	CbGpPWpGaD
Boceprevir—Fatigue—Methylprednisolone—asthma	1.63e-05	0.000114	CcSEcCtD
Boceprevir—Pain—Triamcinolone—asthma	1.62e-05	0.000113	CcSEcCtD
Boceprevir—Loss of consciousness—Prednisone—asthma	1.61e-05	0.000112	CcSEcCtD
Boceprevir—Hypotension—Betamethasone—asthma	1.61e-05	0.000112	CcSEcCtD
Boceprevir—Hypotension—Dexamethasone—asthma	1.61e-05	0.000112	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IFNG—asthma	1.6e-05	0.000186	CbGpPWpGaD
Boceprevir—Urticaria—Hydrocortisone—asthma	1.6e-05	0.000112	CcSEcCtD
Boceprevir—Body temperature increased—Hydrocortisone—asthma	1.59e-05	0.000111	CcSEcCtD
Boceprevir—Abdominal pain—Hydrocortisone—asthma	1.59e-05	0.000111	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PPP2CA—asthma	1.59e-05	0.000185	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PTEN—asthma	1.59e-05	0.000185	CbGpPWpGaD
Boceprevir—Hypertension—Prednisone—asthma	1.58e-05	0.00011	CcSEcCtD
Boceprevir—CTSS—Immune System—TLR4—asthma	1.58e-05	0.000184	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HLA-DRB1—asthma	1.58e-05	0.000184	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—EGFR—asthma	1.57e-05	0.000182	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Dexamethasone—asthma	1.57e-05	0.000109	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Betamethasone—asthma	1.57e-05	0.000109	CcSEcCtD
Boceprevir—Arthralgia—Prednisone—asthma	1.56e-05	0.000109	CcSEcCtD
Boceprevir—Myalgia—Prednisone—asthma	1.56e-05	0.000109	CcSEcCtD
Boceprevir—Feeling abnormal—Triamcinolone—asthma	1.56e-05	0.000109	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CCR5—asthma	1.56e-05	0.000182	CbGpPWpGaD
Boceprevir—Feeling abnormal—Methylprednisolone—asthma	1.56e-05	0.000109	CcSEcCtD
Boceprevir—Anxiety—Prednisone—asthma	1.56e-05	0.000109	CcSEcCtD
Boceprevir—Insomnia—Dexamethasone—asthma	1.56e-05	0.000108	CcSEcCtD
Boceprevir—Insomnia—Betamethasone—asthma	1.56e-05	0.000108	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	1.55e-05	0.000108	CcSEcCtD
Boceprevir—Gastrointestinal pain—Methylprednisolone—asthma	1.55e-05	0.000108	CcSEcCtD
Boceprevir—Paraesthesia—Betamethasone—asthma	1.54e-05	0.000108	CcSEcCtD
Boceprevir—Paraesthesia—Dexamethasone—asthma	1.54e-05	0.000108	CcSEcCtD
Boceprevir—Discomfort—Prednisone—asthma	1.54e-05	0.000108	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—IL2RA—asthma	1.54e-05	0.000179	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	1.54e-05	0.000179	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—C3—asthma	1.53e-05	0.000177	CbGpPWpGaD
Boceprevir—Hypersensitivity—Prednisolone—asthma	1.52e-05	0.000106	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—IL6—asthma	1.52e-05	0.000176	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IL6—asthma	1.52e-05	0.000176	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ICAM1—asthma	1.52e-05	0.000176	CbGpPWpGaD
Boceprevir—Dyspepsia—Dexamethasone—asthma	1.51e-05	0.000106	CcSEcCtD
Boceprevir—Dyspepsia—Betamethasone—asthma	1.51e-05	0.000106	CcSEcCtD
Boceprevir—CTSV—Immune System—IL1B—asthma	1.51e-05	0.000175	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1B—asthma	1.51e-05	0.000175	CbGpPWpGaD
Boceprevir—Urticaria—Triamcinolone—asthma	1.51e-05	0.000105	CcSEcCtD
Boceprevir—Urticaria—Methylprednisolone—asthma	1.5e-05	0.000105	CcSEcCtD
Boceprevir—CTSV—Immune System—IL2—asthma	1.5e-05	0.000175	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL2—asthma	1.5e-05	0.000175	CbGpPWpGaD
Boceprevir—Body temperature increased—Triamcinolone—asthma	1.5e-05	0.000104	CcSEcCtD
Boceprevir—Abdominal pain—Methylprednisolone—asthma	1.5e-05	0.000104	CcSEcCtD
Boceprevir—Decreased appetite—Betamethasone—asthma	1.5e-05	0.000104	CcSEcCtD
Boceprevir—Decreased appetite—Dexamethasone—asthma	1.5e-05	0.000104	CcSEcCtD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC26A4—asthma	1.49e-05	0.000174	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CXCL8—asthma	1.49e-05	0.000173	CbGpPWpGaD
Boceprevir—Infection—Prednisone—asthma	1.49e-05	0.000104	CcSEcCtD
Boceprevir—CYP3A4—Biological oxidations—ALDH2—asthma	1.49e-05	0.000173	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PDGFB—asthma	1.49e-05	0.000173	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Dexamethasone—asthma	1.49e-05	0.000104	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Betamethasone—asthma	1.49e-05	0.000104	CcSEcCtD
Boceprevir—Hypersensitivity—Hydrocortisone—asthma	1.48e-05	0.000103	CcSEcCtD
Boceprevir—Fatigue—Betamethasone—asthma	1.48e-05	0.000103	CcSEcCtD
Boceprevir—Fatigue—Dexamethasone—asthma	1.48e-05	0.000103	CcSEcCtD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	1.48e-05	0.000172	CbGpPWpGaD
Boceprevir—Shock—Prednisone—asthma	1.47e-05	0.000103	CcSEcCtD
Boceprevir—Pain—Betamethasone—asthma	1.47e-05	0.000103	CcSEcCtD
Boceprevir—Pain—Dexamethasone—asthma	1.47e-05	0.000103	CcSEcCtD
Boceprevir—Nervous system disorder—Prednisone—asthma	1.47e-05	0.000102	CcSEcCtD
Boceprevir—Tachycardia—Prednisone—asthma	1.46e-05	0.000102	CcSEcCtD
Boceprevir—Skin disorder—Prednisone—asthma	1.46e-05	0.000101	CcSEcCtD
Boceprevir—Hyperhidrosis—Prednisone—asthma	1.45e-05	0.000101	CcSEcCtD
Boceprevir—Asthenia—Hydrocortisone—asthma	1.44e-05	0.000101	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL1B—asthma	1.43e-05	0.000166	CbGpPWpGaD
Boceprevir—Pruritus—Hydrocortisone—asthma	1.42e-05	9.93e-05	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL2—asthma	1.42e-05	0.000165	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—LEP—asthma	1.42e-05	0.000165	CbGpPWpGaD
Boceprevir—Feeling abnormal—Dexamethasone—asthma	1.42e-05	9.88e-05	CcSEcCtD
Boceprevir—Feeling abnormal—Betamethasone—asthma	1.42e-05	9.88e-05	CcSEcCtD
Boceprevir—CYP3A4—Biological oxidations—GSTT1—asthma	1.41e-05	0.000164	CbGpPWpGaD
Boceprevir—CTSK—Immune System—BCL2—asthma	1.41e-05	0.000164	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PTEN—asthma	1.41e-05	0.000164	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PTEN—asthma	1.41e-05	0.000164	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—asthma	1.41e-05	0.000164	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Dexamethasone—asthma	1.41e-05	9.81e-05	CcSEcCtD
Boceprevir—Gastrointestinal pain—Betamethasone—asthma	1.41e-05	9.81e-05	CcSEcCtD
Boceprevir—CTSK—Immune System—IFNG—asthma	1.4e-05	0.000163	CbGpPWpGaD
Boceprevir—Hypersensitivity—Triamcinolone—asthma	1.4e-05	9.74e-05	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—asthma	1.4e-05	0.000162	CbGpPWpGaD
Boceprevir—Hypersensitivity—Methylprednisolone—asthma	1.39e-05	9.72e-05	CcSEcCtD
Boceprevir—Diarrhoea—Hydrocortisone—asthma	1.38e-05	9.6e-05	CcSEcCtD
Boceprevir—CYP3A5—Biological oxidations—POMC—asthma	1.37e-05	0.000159	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ATP4A—asthma	1.37e-05	0.000159	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC30A8—asthma	1.37e-05	0.000159	CbGpPWpGaD
Boceprevir—Urticaria—Betamethasone—asthma	1.37e-05	9.53e-05	CcSEcCtD
Boceprevir—Urticaria—Dexamethasone—asthma	1.37e-05	9.53e-05	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Prednisone—asthma	1.36e-05	9.52e-05	CcSEcCtD
Boceprevir—Dizziness—Prednisolone—asthma	1.36e-05	9.5e-05	CcSEcCtD
Boceprevir—Asthenia—Triamcinolone—asthma	1.36e-05	9.48e-05	CcSEcCtD
Boceprevir—Body temperature increased—Dexamethasone—asthma	1.36e-05	9.48e-05	CcSEcCtD
Boceprevir—Abdominal pain—Betamethasone—asthma	1.36e-05	9.48e-05	CcSEcCtD
Boceprevir—Body temperature increased—Betamethasone—asthma	1.36e-05	9.48e-05	CcSEcCtD
Boceprevir—Abdominal pain—Dexamethasone—asthma	1.36e-05	9.48e-05	CcSEcCtD
Boceprevir—Asthenia—Methylprednisolone—asthma	1.36e-05	9.46e-05	CcSEcCtD
Boceprevir—Insomnia—Prednisone—asthma	1.35e-05	9.45e-05	CcSEcCtD
Boceprevir—CTSK—Immune System—CD4—asthma	1.35e-05	0.000157	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6R—asthma	1.35e-05	0.000157	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—EGFR—asthma	1.35e-05	0.000156	CbGpPWpGaD
Boceprevir—Paraesthesia—Prednisone—asthma	1.35e-05	9.38e-05	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	1.34e-05	0.000156	CbGpPWpGaD
Boceprevir—Pruritus—Triamcinolone—asthma	1.34e-05	9.35e-05	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—FN1—asthma	1.34e-05	0.000156	CbGpPWpGaD
Boceprevir—Pruritus—Methylprednisolone—asthma	1.34e-05	9.33e-05	CcSEcCtD
Boceprevir—Dizziness—Hydrocortisone—asthma	1.33e-05	9.28e-05	CcSEcCtD
Boceprevir—Dyspepsia—Prednisone—asthma	1.32e-05	9.19e-05	CcSEcCtD
Boceprevir—Decreased appetite—Prednisone—asthma	1.3e-05	9.08e-05	CcSEcCtD
Boceprevir—Rash—Prednisolone—asthma	1.3e-05	9.06e-05	CcSEcCtD
Boceprevir—Dermatitis—Prednisolone—asthma	1.3e-05	9.05e-05	CcSEcCtD
Boceprevir—Diarrhoea—Methylprednisolone—asthma	1.29e-05	9.02e-05	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—EGFR—asthma	1.29e-05	0.00015	CbGpPWpGaD
Boceprevir—Fatigue—Prednisone—asthma	1.29e-05	9e-05	CcSEcCtD
Boceprevir—Headache—Prednisolone—asthma	1.29e-05	9e-05	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—LTC4S—asthma	1.29e-05	0.00015	CbGpPWpGaD
Boceprevir—Constipation—Prednisone—asthma	1.28e-05	8.93e-05	CcSEcCtD
Boceprevir—Vomiting—Hydrocortisone—asthma	1.28e-05	8.93e-05	CcSEcCtD
Boceprevir—Rash—Hydrocortisone—asthma	1.27e-05	8.85e-05	CcSEcCtD
Boceprevir—Dermatitis—Hydrocortisone—asthma	1.27e-05	8.84e-05	CcSEcCtD
Boceprevir—CTSL—Immune System—STAT3—asthma	1.26e-05	0.000147	CbGpPWpGaD
Boceprevir—CTSV—Immune System—STAT3—asthma	1.26e-05	0.000147	CbGpPWpGaD
Boceprevir—Headache—Hydrocortisone—asthma	1.26e-05	8.79e-05	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—IL6—asthma	1.26e-05	0.000146	CbGpPWpGaD
Boceprevir—Dizziness—Triamcinolone—asthma	1.25e-05	8.74e-05	CcSEcCtD
Boceprevir—Dizziness—Methylprednisolone—asthma	1.25e-05	8.72e-05	CcSEcCtD
Boceprevir—CTSK—Immune System—IL1B—asthma	1.25e-05	0.000145	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL2—asthma	1.24e-05	0.000145	CbGpPWpGaD
Boceprevir—Feeling abnormal—Prednisone—asthma	1.23e-05	8.61e-05	CcSEcCtD
Boceprevir—Asthenia—Betamethasone—asthma	1.23e-05	8.61e-05	CcSEcCtD
Boceprevir—Asthenia—Dexamethasone—asthma	1.23e-05	8.61e-05	CcSEcCtD
Boceprevir—Gastrointestinal pain—Prednisone—asthma	1.23e-05	8.54e-05	CcSEcCtD
Boceprevir—Nausea—Prednisolone—asthma	1.22e-05	8.54e-05	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—POMC—asthma	1.22e-05	0.000142	CbGpPWpGaD
Boceprevir—Pruritus—Dexamethasone—asthma	1.22e-05	8.49e-05	CcSEcCtD
Boceprevir—Pruritus—Betamethasone—asthma	1.22e-05	8.49e-05	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—asthma	1.21e-05	0.000141	CbGpPWpGaD
Boceprevir—Vomiting—Triamcinolone—asthma	1.21e-05	8.4e-05	CcSEcCtD
Boceprevir—Vomiting—Methylprednisolone—asthma	1.2e-05	8.39e-05	CcSEcCtD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	1.2e-05	0.000139	CbGpPWpGaD
Boceprevir—Nausea—Hydrocortisone—asthma	1.2e-05	8.34e-05	CcSEcCtD
Boceprevir—Rash—Triamcinolone—asthma	1.2e-05	8.33e-05	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CCL2—asthma	1.19e-05	0.000139	CbGpPWpGaD
Boceprevir—Dermatitis—Triamcinolone—asthma	1.19e-05	8.33e-05	CcSEcCtD
Boceprevir—Rash—Methylprednisolone—asthma	1.19e-05	8.32e-05	CcSEcCtD
Boceprevir—Dermatitis—Methylprednisolone—asthma	1.19e-05	8.31e-05	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—IL6R—asthma	1.19e-05	0.000138	CbGpPWpGaD
Boceprevir—Urticaria—Prednisone—asthma	1.19e-05	8.3e-05	CcSEcCtD
Boceprevir—Headache—Triamcinolone—asthma	1.19e-05	8.28e-05	CcSEcCtD
Boceprevir—Headache—Methylprednisolone—asthma	1.19e-05	8.26e-05	CcSEcCtD
Boceprevir—Abdominal pain—Prednisone—asthma	1.18e-05	8.26e-05	CcSEcCtD
Boceprevir—Body temperature increased—Prednisone—asthma	1.18e-05	8.26e-05	CcSEcCtD
Boceprevir—Diarrhoea—Dexamethasone—asthma	1.18e-05	8.21e-05	CcSEcCtD
Boceprevir—Diarrhoea—Betamethasone—asthma	1.18e-05	8.21e-05	CcSEcCtD
Boceprevir—CTSK—Immune System—PTEN—asthma	1.17e-05	0.000136	CbGpPWpGaD
Boceprevir—CTSS—Immune System—BCL2—asthma	1.16e-05	0.000135	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IFNG—asthma	1.15e-05	0.000134	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EGFR—asthma	1.15e-05	0.000133	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EGFR—asthma	1.15e-05	0.000133	CbGpPWpGaD
Boceprevir—Dizziness—Dexamethasone—asthma	1.14e-05	7.93e-05	CcSEcCtD
Boceprevir—Dizziness—Betamethasone—asthma	1.14e-05	7.93e-05	CcSEcCtD
Boceprevir—Nausea—Triamcinolone—asthma	1.13e-05	7.85e-05	CcSEcCtD
Boceprevir—Nausea—Methylprednisolone—asthma	1.12e-05	7.83e-05	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—asthma	1.12e-05	0.00013	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LTA4H—asthma	1.12e-05	0.00013	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SERPINE1—asthma	1.12e-05	0.00013	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD4—asthma	1.11e-05	0.000129	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TGFB1—asthma	1.11e-05	0.000129	CbGpPWpGaD
Boceprevir—Hypersensitivity—Prednisone—asthma	1.1e-05	7.7e-05	CcSEcCtD
Boceprevir—Vomiting—Dexamethasone—asthma	1.09e-05	7.63e-05	CcSEcCtD
Boceprevir—Vomiting—Betamethasone—asthma	1.09e-05	7.63e-05	CcSEcCtD
Boceprevir—Rash—Dexamethasone—asthma	1.08e-05	7.56e-05	CcSEcCtD
Boceprevir—Rash—Betamethasone—asthma	1.08e-05	7.56e-05	CcSEcCtD
Boceprevir—Dermatitis—Betamethasone—asthma	1.08e-05	7.56e-05	CcSEcCtD
Boceprevir—Dermatitis—Dexamethasone—asthma	1.08e-05	7.56e-05	CcSEcCtD
Boceprevir—Headache—Betamethasone—asthma	1.08e-05	7.51e-05	CcSEcCtD
Boceprevir—Headache—Dexamethasone—asthma	1.08e-05	7.51e-05	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—RHOA—asthma	1.08e-05	0.000125	CbGpPWpGaD
Boceprevir—Asthenia—Prednisone—asthma	1.07e-05	7.49e-05	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—NOS3—asthma	1.06e-05	0.000124	CbGpPWpGaD
Boceprevir—Pruritus—Prednisone—asthma	1.06e-05	7.39e-05	CcSEcCtD
Boceprevir—CTSK—Immune System—STAT3—asthma	1.05e-05	0.000122	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—asthma	1.04e-05	0.00012	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—asthma	1.03e-05	0.00012	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1B—asthma	1.03e-05	0.00012	CbGpPWpGaD
Boceprevir—Diarrhoea—Prednisone—asthma	1.03e-05	7.15e-05	CcSEcCtD
Boceprevir—CTSS—Immune System—IL2—asthma	1.02e-05	0.000119	CbGpPWpGaD
Boceprevir—Nausea—Dexamethasone—asthma	1.02e-05	7.12e-05	CcSEcCtD
Boceprevir—Nausea—Betamethasone—asthma	1.02e-05	7.12e-05	CcSEcCtD
Boceprevir—Dizziness—Prednisone—asthma	9.91e-06	6.91e-05	CcSEcCtD
Boceprevir—CYP3A4—Biological oxidations—GSTP1—asthma	9.8e-06	0.000114	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ARG1—asthma	9.78e-06	0.000114	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LTC4S—asthma	9.74e-06	0.000113	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTP1—asthma	9.66e-06	0.000112	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTEN—asthma	9.64e-06	0.000112	CbGpPWpGaD
Boceprevir—Vomiting—Prednisone—asthma	9.53e-06	6.64e-05	CcSEcCtD
Boceprevir—CTSK—Immune System—EGFR—asthma	9.52e-06	0.000111	CbGpPWpGaD
Boceprevir—Rash—Prednisone—asthma	9.45e-06	6.59e-05	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CXCL8—asthma	9.44e-06	0.00011	CbGpPWpGaD
Boceprevir—Dermatitis—Prednisone—asthma	9.44e-06	6.58e-05	CcSEcCtD
Boceprevir—Headache—Prednisone—asthma	9.39e-06	6.54e-05	CcSEcCtD
Boceprevir—ABCB1—Transmembrane transport of small molecules—CARM1—asthma	9.19e-06	0.000107	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2—asthma	9.03e-06	0.000105	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—GSTM1—asthma	9e-06	0.000105	CbGpPWpGaD
Boceprevir—Nausea—Prednisone—asthma	8.9e-06	6.2e-05	CcSEcCtD
Boceprevir—CYP3A4—Metapathway biotransformation—GSTM1—asthma	8.88e-06	0.000103	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALDH7A1—asthma	8.85e-06	0.000103	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—asthma	8.83e-06	0.000103	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—asthma	8.83e-06	0.000103	CbGpPWpGaD
Boceprevir—CTSS—Immune System—STAT3—asthma	8.62e-06	0.0001	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—asthma	8.54e-06	9.93e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTEN—asthma	8.49e-06	9.87e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ARG2—asthma	8.48e-06	9.86e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LTA4H—asthma	8.45e-06	9.82e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—asthma	7.98e-06	9.27e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—asthma	7.84e-06	9.11e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—asthma	7.67e-06	8.92e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—STAT3—asthma	7.6e-06	8.83e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	7.58e-06	8.81e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ARG1—asthma	7.38e-06	8.58e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—asthma	7.31e-06	8.5e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TGFB1—asthma	7.04e-06	8.18e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALOX5AP—asthma	7.03e-06	8.17e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALOX15—asthma	7.03e-06	8.17e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—asthma	6.9e-06	8.02e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ADCY2—asthma	6.81e-06	7.92e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CHAT—asthma	6.71e-06	7.79e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALDH7A1—asthma	6.68e-06	7.76e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—asthma	6.61e-06	7.68e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ARG2—asthma	6.4e-06	7.44e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—POMC—asthma	6.36e-06	7.4e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—asthma	6.02e-06	7e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LTC4S—asthma	6e-06	6.98e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALOX5—asthma	5.98e-06	6.95e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	5.97e-06	6.94e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—HMOX1—asthma	5.73e-06	6.66e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CARM1—asthma	5.7e-06	6.63e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—DCN—asthma	5.62e-06	6.53e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	5.48e-06	6.37e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALDH2—asthma	5.47e-06	6.35e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—asthma	5.37e-06	6.24e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—asthma	5.31e-06	6.17e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALOX15—asthma	5.3e-06	6.16e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALOX5AP—asthma	5.3e-06	6.16e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LTA4H—asthma	5.2e-06	6.05e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTT1—asthma	5.2e-06	6.04e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—asthma	5.11e-06	5.94e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CHAT—asthma	5.06e-06	5.88e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ARG1—asthma	4.55e-06	5.29e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALOX5—asthma	4.51e-06	5.24e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NQO1—asthma	4.32e-06	5.02e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CARM1—asthma	4.3e-06	5e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—DCN—asthma	4.24e-06	4.93e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ADCY2—asthma	4.23e-06	4.91e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALDH2—asthma	4.12e-06	4.79e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALDH7A1—asthma	4.11e-06	4.78e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ARG2—asthma	3.94e-06	4.58e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTT1—asthma	3.92e-06	4.56e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTP1—asthma	3.6e-06	4.19e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HMOX1—asthma	3.55e-06	4.13e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ITPR1—asthma	3.55e-06	4.12e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CAT—asthma	3.51e-06	4.08e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ALB—asthma	3.44e-06	4e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLA2G4A—asthma	3.31e-06	3.85e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTM1—asthma	3.31e-06	3.85e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALOX15—asthma	3.27e-06	3.8e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALOX5AP—asthma	3.27e-06	3.8e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NQO1—asthma	3.26e-06	3.79e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ADCY2—asthma	3.19e-06	3.71e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CHAT—asthma	3.12e-06	3.62e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPP2CA—asthma	3.05e-06	3.55e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALOX5—asthma	2.78e-06	3.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTP1—asthma	2.72e-06	3.16e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HMOX1—asthma	2.68e-06	3.12e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ITPR1—asthma	2.68e-06	3.11e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CARM1—asthma	2.65e-06	3.08e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CAT—asthma	2.65e-06	3.08e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—DCN—asthma	2.61e-06	3.04e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALDH2—asthma	2.54e-06	2.95e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLA2G4A—asthma	2.5e-06	2.9e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTM1—asthma	2.5e-06	2.9e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTT1—asthma	2.42e-06	2.81e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—POMC—asthma	2.34e-06	2.72e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPP2CA—asthma	2.3e-06	2.68e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALB—asthma	2.13e-06	2.48e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NOS3—asthma	2.04e-06	2.37e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NQO1—asthma	2.01e-06	2.33e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ADCY2—asthma	1.97e-06	2.28e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—asthma	1.87e-06	2.17e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—POMC—asthma	1.77e-06	2.05e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTP1—asthma	1.68e-06	1.95e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HMOX1—asthma	1.65e-06	1.92e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ITPR1—asthma	1.65e-06	1.92e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CAT—asthma	1.63e-06	1.89e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTEN—asthma	1.63e-06	1.89e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALB—asthma	1.61e-06	1.87e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NOS3—asthma	1.54e-06	1.79e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLA2G4A—asthma	1.54e-06	1.79e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTM1—asthma	1.54e-06	1.79e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPP2CA—asthma	1.42e-06	1.65e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—asthma	1.41e-06	1.64e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTEN—asthma	1.23e-06	1.43e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—POMC—asthma	1.09e-06	1.26e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALB—asthma	9.92e-07	1.15e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NOS3—asthma	9.49e-07	1.1e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—asthma	8.68e-07	1.01e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTEN—asthma	7.57e-07	8.8e-06	CbGpPWpGaD
